Microdialysis of intercellular adenosine concentration in subcutaneous tissue in humans.

Adenosine kinase: exploitation for therapeutic gain. Pharmacol Rev (2013) 1.26

Glycerol production in subcutaneous adipose tissue in lean and obese humans. J Clin Invest (1992) 1.24

Overview of brain microdialysis. Curr Protoc Neurosci (2009) 1.05

Resistance to the antilipolytic effect of insulin in adipocytes of African-American compared to Caucasian postmenopausal women. J Lipid Res (2009) 0.99

Lactate release from the subcutaneous tissue in lean and obese men. J Clin Invest (1994) 0.98

Beta-adrenergic stimulation of adenine nucleotide catabolism and purine release in human adipocytes. J Clin Invest (1990) 0.93

Greater systemic lipolysis in women compared with men during moderate-dose infusion of epinephrine and/or norepinephrine. J Appl Physiol (1985) (2009) 0.93

Adenosine A(3) receptors regulate heart rate, motor activity and body temperature. Acta Physiol (Oxf) (2010) 0.87

Gentamicin concentrations in human subcutaneous tissue. Antimicrob Agents Chemother (1996) 0.82

Overview of microdialysis. Curr Protoc Neurosci (2001) 0.78

Microdialysis in rodents. Curr Protoc Neurosci (2009) 0.77

Validation of a new calibration method for human muscle microdialysis at rest and during exercise. Eur J Appl Physiol (2004) 0.75

Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest (1983) 4.70

Does diabetes therapy influence the risk of cancer? Diabetologia (2009) 3.66

Structure of Rhodopseudomonas sphaeroides R-26 reaction center. FEBS Lett (1986) 3.28

Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci U S A (2001) 2.73

A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol (1987) 2.63

Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol (1998) 2.43

Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med (1990) 2.25

Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci (1997) 2.23

How does adenosine inhibit transmitter release? Trends Pharmacol Sci (1988) 2.20

Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study. Diabetologia (2007) 2.16

A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid. Anal Biochem (1990) 2.11

Effects of adenosine on adrenergic neurotransmission; prejunctional inhibition and postjunctional enhancement. Naunyn Schmiedebergs Arch Pharmacol (1976) 2.09

The birth and postnatal development of purinergic signalling. Acta Physiol (Oxf) (2010) 2.06

Smoking induces insulin resistance--a potential link with the insulin resistance syndrome. J Intern Med (1993) 2.01

Effect of cardioselective and non-selective beta-blockade on the hypoglycaemic response in insulin-dependent diabetics. Lancet (1979) 2.01

Modulation of neurotransmission by purine nucleotides and nucleosides. Biochem Pharmacol (1980) 1.81

Distribution, biochemistry and function of striatal adenosine A2A receptors. Prog Neurobiol (1999) 1.76

Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1997) 1.73

Diabetes-induced hyperfiltration in adenosine A(1)-receptor deficient mice lacking the tubuloglomerular feedback mechanism. Acta Physiol (Oxf) (2007) 1.71

Phycocyanobilin. Structure and exchange studies by nuclear magnetic resonance and its mode of attachment in phycocyanin. A model for phytochrome. Biochemistry (1968) 1.67

Evidence for lactate production by human adipose tissue in vivo. Diabetologia (1990) 1.63

Xanthine derivatives as adenosine receptor antagonists. Eur J Pharmacol (1982) 1.62

On the mechanism of relaxation of tracheal muscle by theophylline and other cyclic nucleotide phosphodiesterase inhibitors. Acta Pharmacol Toxicol (Copenh) (1979) 1.58

The organization and myofilament array of insect visceral muscles. J Cell Sci (1966) 1.57

Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer? Diabetologia (2007) 1.56

Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun (2001) 1.54

The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients--the EUGENE2 study. Diabetologia (2008) 1.53

Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes (1996) 1.52

Lipid intolerance in smokers. J Intern Med (1995) 1.48

Angiotensin I: metabolism by plasma membrane of lung. Science (1972) 1.45

Isolation and characterization of cells from rat adipose tissue developing into adipocytes. J Lipid Res (1978) 1.43

Adenosine increases LPS-induced nuclear factor kappa B activation in smooth muscle cells via an intracellular mechanism and modulates it via actions on adenosine receptors. Acta Physiol (Oxf) (2013) 1.42

Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulin-stimulated glucose transport. FASEB J (2001) 1.41

Inhibition of sodium-linked glucose reabsorption normalizes diabetes-induced glomerular hyperfiltration in conscious adenosine A₁-receptor deficient mice. Acta Physiol (Oxf) (2013) 1.40

Electron microscopy of endothelial and epithelial components of the lungs: correlations of structure and function. Fed Proc (1973) 1.40

Adenosine and brain ischemia. Cerebrovasc Brain Metab Rev (1992) 1.40

Fat cell metabolism in different regions in women. Effect of menstrual cycle, pregnancy, and lactation. J Clin Invest (1985) 1.40

Adenosine-dopamine interactions in the brain. Neuroscience (1992) 1.39

Adenosine signaling and function in glial cells. Cell Death Differ (2009) 1.39

The release of adenosine and inosine from canine subcutaneous adipose tissue by nerve stimulation and noradrenaline. J Physiol (1981) 1.39

Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc Natl Acad Sci U S A (1991) 1.39

Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol Sci (1992) 1.38

Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance. J Clin Endocrinol Metab (1999) 1.37

Adenosine receptors. Med Biol (1982) 1.37

Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol (1999) 1.35

Purine levels in the intact rat brain. Studies with an implanted perfused hollow fibre. Neurosci Lett (1982) 1.34

Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. J Intern Med (1991) 1.30

Characterization by microdialysis of intracellular glucose level in subcutaneous tissue in humans. Am J Physiol (1988) 1.30

Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc Natl Acad Sci U S A (2000) 1.30

Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons. Neuroscience (1998) 1.29

Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat. Neurosci Lett (1985) 1.29

Counter-regulation of insulin-stimulated glucose transport by catecholamines in the isolated rat adipose cell. J Biol Chem (1984) 1.29

Human adenosine A(1), A(2A), A(2B), and A(3) receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2. Mol Pharmacol (2000) 1.29

Body fat and adipose tissue cellularity in infants: a longitudinal study. Metabolism (1977) 1.28

Neuropeptide Y receptor in pig spleen: binding characteristics, reduction of cyclic AMP formation and calcium antagonist inhibition of vasoconstriction. Eur J Pharmacol (1988) 1.28

Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes (2003) 1.28

Regional adipose tissue cellularity in relation to metabolism in young and middle-aged women. Metabolism (1975) 1.28

Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest (1997) 1.27

Adenosine A(2A) receptors are colocalized with and activate g(olf) in rat striatum. Mol Pharmacol (2000) 1.27

Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism. Acta Physiol Scand (1991) 1.27

Effect of theophylline and other drugs on rabbit renal cyclic nucleotide phosphodiesterase, 5'-nucleotidase and adenosine deaminase. Biochem Pharmacol (1978) 1.27

Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol Sci (1996) 1.25

Isomerization of prostaglandin H2 into prostaglandin D2 in the presence of serum albumin. Biochim Biophys Acta (1976) 1.25

Exocytosis in the adrenal medulla demonstrated by freeze-etching. Science (1973) 1.25

Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice. Diabetologia (2008) 1.25

Metabolism of adenosine 5'-monophosphate during circulation through the lungs. Trans Assoc Am Physicians (1971) 1.25

Glycerol production in subcutaneous adipose tissue in lean and obese humans. J Clin Invest (1992) 1.24

Endothelial projections as revealed by scanning electron microscopy. Science (1971) 1.24

Inhibitory effect of adenosine on adrenergic neuroeffector transmission in the rabbit heart. Acta Physiol Scand (1979) 1.23

Pharmacology of adenosine A2A receptors. Trends Pharmacol Sci (1996) 1.23

ATP and its metabolite adenosine act synergistically to mobilize intracellular calcium via the formation of inositol 1,4,5-trisphosphate in a smooth muscle cell line. J Biol Chem (1992) 1.23

Effect of beta-adrenoceptor blockade on exercise performance and metabolism. Clin Sci (Lond) (1981) 1.23

Comparison of two methods for determining human adipose cell size. J Lipid Res (1972) 1.23

Reduced expression of PGC-1 and insulin-signaling molecules in adipose tissue is associated with insulin resistance. Biochem Biophys Res Commun (2003) 1.23

Regional differences and effect of weight reduction on human fat cell metabolism. Eur J Clin Invest (1979) 1.22

Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion. Br Med J (Clin Res Ed) (1983) 1.22

Intracellular formation and release of adenosine from rat hippocampal slices evoked by electrical stimulation or energy depletion. Neurochem Int (1993) 1.21

Adenosine analogues depress ventilation in rabbit neonates. Theophylline stimulation of respiration via adenosine receptors? Pediatr Res (1984) 1.21

Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus. J Pharmacol Exp Ther (1989) 1.20

A rapid, simple method for isolating pinocytotic vesicles and plasma membrane of lung. Biochim Biophys Acta (1971) 1.19

Antagonistic effects of theophylline and adenosine on adrenergic neuroeffector transmission in the rabbit kidney. Circ Res (1978) 1.19

Adenosine receptors mediating cyclic AMP production in the rat hippocampus. J Neurochem (1982) 1.19

Caffeine--an atypical drug of dependence. Drug Alcohol Depend (1998) 1.19

On the mechanism of action of theophylline and caffeine. Acta Med Scand (1985) 1.18

Differences in metabolic responses to beta-adrenergic stimulation after propranolol or metoprolol administration. Acta Med Scand (1979) 1.18

Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation (1996) 1.17

Evidence for functionally important adenosine A2a receptors in the rat hippocampus. Brain Res (1994) 1.17

A novel 8-phenyl-substituted xanthine derivative is a selective antagonist at adenosine A1-receptors in vivo. Acta Physiol Scand (1985) 1.16

Neuropeptide Y is a potent inhibitor of cyclic AMP accumulation in feline cerebral blood vessels. Acta Physiol Scand (1985) 1.15

Glucose uptake in human adipose tissue. Metabolism (1987) 1.15

Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience (1997) 1.14

Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes (1990) 1.14

Characterization of bacterial photosynthetic reaction center crystals from Rhodopseudomonas sphaeroides R-26 by X-ray diffraction. J Mol Biol (1985) 1.14

Localization of adenosine receptor messenger RNAs in the rat eye. Exp Eye Res (1997) 1.13

Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism (1990) 1.12

Order! Order! Order in the House! DIAMAP: a road map for European diabetes research. Diabetologia (2008) 1.11

Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM. FASEB J (1999) 1.11